Merck Aktie
138,20
EUR
-0,05
EUR
-0,04
%
Kursziele der Merck-Aktie in EUR
Das durchschnittliche Kursziel beinhaltet alle Analysen eines Analysten und nicht nur die jeweils aktuellste Analyse, die im Chart dargestellt wird.
Diese Analysten bewerten die Merck-Aktie
| Analyst | Kursziel | Abstand Kursziel | Datum | |
|---|---|---|---|---|
| JP Morgan Chase & Co. | 190,00 EUR | +37,43% | 18.11.2024 | |
| Deutsche Bank AG | 180,00 EUR | +30,20% | 15.11.2024 | |
| UBS AG | 190,00 EUR | +37,43% | 15.11.2024 | |
| Goldman Sachs Group Inc. | 196,00 EUR | +41,77% | 15.11.2024 | |
| Jefferies & Company Inc. | 180,00 EUR | +30,20% | 14.11.2024 | |
| Bernstein Research | 176,00 EUR | +27,31% | 18.10.2024 | |
| DZ BANK | - | - | 05.08.2024 | |
| Barclays Capital | 195,00 EUR | +41,05% | 01.08.2024 |
Kursziele im Branchenvergleich
| Aktie | Buy | Hold | Sell | Ø Kursziel | Abst. Kursziel |
|---|---|---|---|---|---|
| 3M Co. | 0 | 0 | 0 | - | - |
| Abbott Laboratories | 0 | 0 | 0 | - | - |
| AstraZeneca PLC | 5 | 4 | 0 | 135,44 GBP | - |
| BASF | 6 | 5 | 0 | 51,11 EUR | +22,57% |
| Bayer | 1 | 9 | 0 | 28,11 EUR | +45,89% |
| BB Biotech AG | 0 | 0 | 0 | - | - |
| Beiersdorf AG | 6 | 4 | 1 | 142,80 EUR | +18,65% |
| Biotest AG Vz. | 0 | 0 | 0 | - | - |
| Bristol-Myers Squibb Co. | 0 | 0 | 0 | - | - |
| Clorox Co., The | 0 | 0 | 0 | - | - |
| Colgate-Palmolive Co. | 0 | 0 | 0 | - | - |
| Eli Lilly | 1 | 0 | 0 | 994,00 USD | +31,93% |
| Gilead Sciences Inc. | 0 | 0 | 0 | - | - |
| GSK PLC Registered Shs | 2 | 6 | 1 | 17,18 GBP | +31,30% |
| H. B. Fuller Co. | 0 | 0 | 0 | - | - |
| H&R GmbH & Co. KGaA | 0 | 1 | 0 | - | - |
| Johnson & Johnson | 0 | 0 | 0 | - | - |
| L'Oréal S.A. (L'Oreal, L Oreal) | 4 | 4 | 2 | 430,12 EUR | +33,93% |
| LANXESS AG | 5 | 2 | 3 | 28,44 EUR | +21,96% |
| Merck Co. | 0 | 0 | 0 | - | - |
| Merck KGaA | 7 | 1 | 0 | 186,71 EUR | +35,05% |
| Novartis AG | 3 | 5 | 1 | 99,62 CHF | +9,67% |
| Pfizer Inc. | 3 | 3 | 0 | 30,80 USD | +23,50% |
| Procter & Gamble Co. | 0 | 0 | 0 | - | - |
| Reckitt Benckiser Plc | 4 | 6 | 0 | 54,23 GBP | +14,36% |
| Roche Holding AG (Inhaberaktie) | 0 | 0 | 0 | - | - |
| Sanofi S.A. | 5 | 2 | 1 | 109,86 EUR | +20,71% |
| STADA | 0 | 0 | 0 | - | - |
| Takeda Pharmaceutical Co. Ltd. | 0 | 0 | 0 | - | - |
| Unilever plc | 4 | 4 | 2 | 47,87 GBP | - |
| WACKER CHEMIE AG | 5 | 3 | 0 | 113,29 EUR | +56,22% |